{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:53:51Z","timestamp":1750308831290,"version":"3.41.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,18]]},"DOI":"10.7759\/cureus.86303","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T20:34:21Z","timestamp":1750278861000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics and Cardiac Magnetic Resonance Findings in Patients With Hypertrophic Cardiomyopathy in Brunei Darussalam"],"prefix":"10.7759","author":[{"given":"Kah Cheong","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazar Luqman","family":"Bilgrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000097621.97566.96","article-title":"Hypertrophic cardiomyopathy: a patient perspective","volume":"108","author":"Nishimura RA","year":"2003","unstructured":"Nishimura RA, Ommen SR, Tajik AJ. Hypertrophic cardiomyopathy: a patient perspective. Circulation. 2003, 108:e133-5. 10.1161\/01.CIR.0000097621.97566.96","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.08.1032","article-title":"Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas","volume":"61","author":"Chandra N","year":"2013","unstructured":"Chandra N, Bastiaenen R, Papadakis M, Sharma S. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol. 2013, 61:1027-40. 10.1016\/j.jacc.2012.08.1032","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01778-8","article-title":"Long-term outcome in patients with apical hypertrophic cardiomyopathy","volume":"39","author":"Eriksson MJ","year":"2002","unstructured":"Eriksson MJ, Sonnenberg B, Woo A, et al.. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002, 39:638-45. 10.1016\/S0735-1097(01)01778-8","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318223e2bd","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh BJ","year":"2011","unstructured":"Gersh BJ, Maron BJ, Bonow RO, et al.. 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2011, 124:e783-831. 10.1161\/CIR.0b013e318223e2bd","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon R","year":"2010","unstructured":"O'Hanlon R, Grasso A, Roughton M, et al.. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010, 56:867-74. 10.1016\/j.jacc.2010.05.010","journal-title":"J Am Coll Cardiol"},{"key":"ref6","article-title":"Assessment of myocardial fibrosis in hypertrophic cardiomyopathy by cardiac magnetic resonance: modalities and clinical applications","volume":"8","author":"Contaldi C","year":"2016","unstructured":"Contaldi C. Assessment of myocardial fibrosis in hypertrophic cardiomyopathy by cardiac magnetic resonance: modalities and clinical applications. ICF J. 2016, 8:3-9.","journal-title":"ICF J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/1995-705X.90900","article-title":"Hypertrophic cardiomyopathy: prevalence, hypertrophy patterns, and their clinical and ECG findings in a hospital at Qatar","volume":"12","author":"Helmy SM","year":"2011","unstructured":"Helmy SM, Maauof GF, Shaaban AA, Elmaghraby AM, Anilkumar S, Shawky AH, Hajar R. Hypertrophic cardiomyopathy: prevalence, hypertrophy patterns, and their clinical and ECG findings in a hospital at Qatar. Heart Views. 2011, 12:143-9. 10.4103\/1995-705X.90900","journal-title":"Heart Views"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12947-016-0072-5","article-title":"Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy","volume":"14","author":"Parato VM","year":"2015","unstructured":"Parato VM, Antoncecchi V, Sozzi F, Marazia S, Zito A, Maiello M, Palmiero P. Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy. Cardiovasc Ultrasound. 2015, 14:30. 10.1186\/s12947-016-0072-5","journal-title":"Cardiovasc Ultrasound"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-14-17","article-title":"The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance","volume":"14","author":"Noureldin RA","year":"2012","unstructured":"Noureldin RA, Liu S, Nacif MS, et al.. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012, 14:17. 10.1186\/1532-429X-14-17","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20057","article-title":"Clinical characteristics and outcomes of hypertrophic cardiomyopathy in Taiwan - a tertiary center experience","volume":"30","author":"Lee CH","year":"2007","unstructured":"Lee CH, Liu PY, Lin LJ, Chen JH, Tsai LM. Clinical characteristics and outcomes of hypertrophic cardiomyopathy in Taiwan - a tertiary center experience. Clin Cardiol. 2007, 30:177-82. 10.1002\/clc.20057","journal-title":"Clin Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.07.027","article-title":"Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States","volume":"92","author":"Kitaoka H","year":"2003","unstructured":"Kitaoka H, Doi Y, Casey SA, Hitomi N, Furuno T, Maron BJ. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol. 2003, 92:1183-6. 10.1016\/j.amjcard.2003.07.027","journal-title":"Am J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott PM","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA, et al.. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014, 35:2733-79. 10.1093\/eurheartj\/ehu284","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2015.03.003","article-title":"Electrocardiographic detection of left ventricular hypertrophy: time to forget the Sokolow-Lyon index?","volume":"108","author":"Courand PY","year":"2015","unstructured":"Courand PY, Lantelme P, Gosse P. Electrocardiographic detection of left ventricular hypertrophy: time to forget the Sokolow-Lyon index?. Arch Cardiovasc Dis. 2015, 108:277-80. 10.1016\/j.acvd.2015.03.003","journal-title":"Arch Cardiovasc Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-15-6","article-title":"Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography","volume":"15","author":"Wong TC","year":"2013","unstructured":"Wong TC, Piehler K, Puntil KS, et al.. Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography. J Cardiovasc Magn Reson. 2013, 15:6. 10.1186\/1532-429X-15-6","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.679","article-title":"Arrhythmias seen in baseline 24-hour Holter ECG recordings in healthy normal volunteers during phase 1 clinical trials","volume":"56","author":"Hingorani P","year":"2016","unstructured":"Hingorani P, Karnad DR, Rohekar P, Kerkar V, Lokhandwala YY, Kothari S. Arrhythmias seen in baseline 24-hour Holter ECG recordings in healthy normal volunteers during phase 1 clinical trials. J Clin Pharmacol. 2016, 56:885-93. 10.1002\/jcph.679","journal-title":"J Clin Pharmacol"},{"key":"ref16","article-title":"Fogoros' Electrophysiologic Testing, 6th Edition","author":"Fogoros RN","year":"2017","unstructured":"Fogoros RN, Mandrola JM. Fogoros' Electrophysiologic Testing, 6th Edition. Wiley-Blackwell, 2017."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2011.986","article-title":"Apical hypertrophic cardiomyopathy presenting as recurrent unexplained syncope","volume":"10","author":"Kasirye Y","year":"2012","unstructured":"Kasirye Y, Manne JR, Epperla N, Bapani S, Garcia-Montilla R. Apical hypertrophic cardiomyopathy presenting as recurrent unexplained syncope. Clin Med Res. 2012, 10:26-31. 10.3121\/cmr.2011.986","journal-title":"Clin Med Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2010.07.004","article-title":"Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study","volume":"56","author":"Kubo T","year":"2010","unstructured":"Kubo T, Kitaoka H, Okawa M, et al.. Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study. J Cardiol. 2010, 56:314-9. 10.1016\/j.jjcc.2010.07.004","journal-title":"J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1885-5857(07)60100-5","article-title":"Detection and quantification of myocardial fibrosis in hypertrophic cardiomyopathy by contrast-enhanced cardiovascular magnetic resonance","volume":"60","author":"Pujadas S","year":"2007","unstructured":"Pujadas S, Carreras F, Arrastio X, et al.. Detection and quantification of myocardial fibrosis in hypertrophic cardiomyopathy by contrast-enhanced cardiovascular magnetic resonance. Rev Esp Cardiol. 2007, 60:10-4. 10.1016\/S1885-5857(07)60100-5","journal-title":"Rev Esp Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-14-76","article-title":"Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction","volume":"14","author":"Ellims AH","year":"2012","unstructured":"Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson. 2012, 14:76. 10.1186\/1532-429X-14-76","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v3.i7.256","article-title":"Apical hypertrophic cardiomyopathy","volume":"3","author":"Yusuf SW","year":"2011","unstructured":"Yusuf SW, Bathina JD, Banchs J, Mouhayar EN, Daher IN. Apical hypertrophic cardiomyopathy. World J Cardiol. 2011, 3:256-9. 10.4330\/wjc.v3.i7.256","journal-title":"World J Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2005.20.2.111","article-title":"Comparison of the clinical features of apical hypertrophic cardiomyopathy versus asymmetric septal hypertrophy in Korea","volume":"20","author":"Yang HS","year":"2005","unstructured":"Yang HS, Song JK, Song JM, et al.. Comparison of the clinical features of apical hypertrophic cardiomyopathy versus asymmetric septal hypertrophy in Korea. Korean J Intern Med. 2005, 20:111-5. 10.3904\/kjim.2005.20.2.111","journal-title":"Korean J Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(02)03004-8","article-title":"Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration","volume":"41","author":"Kofflard MJM","year":"2003","unstructured":"Kofflard MJM, Ten Cate FJ, van der Lee C, van Domburg RT. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol. 2003, 41:987-93. 10.1016\/s0735-1097(02)03004-8","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2015.09.22","article-title":"Dynamic obstruction induced by systolic anterior motion of the mitral valve in a volume-depleted left ventricle: an unexpected cause of acute heart failure in a patient with chronic obstructive pulmonary disease","volume":"7","author":"Kim S","year":"2015","unstructured":"Kim S, Kim SJ, Kim J, Yoon P, Park J, Moon J. Dynamic obstruction induced by systolic anterior motion of the mitral valve in a volume-depleted left ventricle: an unexpected cause of acute heart failure in a patient with chronic obstructive pulmonary disease. J Thorac Dis. 2015, 7:E365-9. 10.3978\/j.issn.2072-1439.2015.09.22","journal-title":"J Thorac Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezr232","article-title":"Modern management of systolic anterior motion of the mitral valve","volume":"41","author":"Ibrahim M","year":"2012","unstructured":"Ibrahim M, Rao C, Ashrafian H, Chaudhry U, Darzi A, Athanasiou T. Modern management of systolic anterior motion of the mitral valve. Eur J Cardiothorac Surg. 2012, 41:1260-70. 10.1093\/ejcts\/ezr232","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2019.07.051","article-title":"Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy","volume":"300","author":"Maurizi N","year":"2020","unstructured":"Maurizi N, Rella V, Fumagalli C, et al.. Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy. Int J Cardiol. 2020, 300:191-5. 10.1016\/j.ijcard.2019.07.051","journal-title":"Int J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/371142-clinical-characteristics-and-cardiac-magnetic-resonance-findings-in-patients-with-hypertrophic-cardiomyopathy-in-brunei-darussalam","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T20:34:23Z","timestamp":1750278863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/371142-clinical-characteristics-and-cardiac-magnetic-resonance-findings-in-patients-with-hypertrophic-cardiomyopathy-in-brunei-darussalam"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.86303","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,18]]}}}